Neurocrine Biosciences, Inc. (NBIX): $102.27

0.48 (+0.47%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Neurocrine Biosciences Inc (NBIX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Neurocrine Biosciences Inc.

Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
20 $163 $98 $122.35 $100.52 21.72%

The Trend in the Analyst Price Target


Over the past 85 days, NBIX's average price target has gone down $6.13.

NBIX reports an average of 23.94% for its upside potential over the past 12 months.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-06-13 20 163 98 122.35 98.61 24.07%
2021-06-05 20 163 98 122.35 94.39 29.62%
2021-05-22 20 163 98 122.35 95.97 27.49%
2021-05-15 20 163 98 122.95 94.60 29.97%
2021-05-08 20 163 98 124.00 91.04 36.2%
2021-04-25 21 163 101 126.86 96.73 31.15%
2021-04-17 21 163 101 127.10 96.58 31.6%
2021-04-10 21 163 101 128.05 93.35 37.17%
2021-04-03 21 163 101 128.48 98.18 30.86%
2021-03-20 21 163 101 128.48 92.22 39.32%
2021-03-13 21 163 101 128.48 97.06 32.37%
2021-03-06 21 163 101 128.48 93.23 37.81%
2021-02-27 21 163 105 129.00 109.51 17.8%
2021-02-20 21 163 105 129.00 113.24 13.92%
2021-02-13 21 163 105 129.00 114.10 13.06%
2021-02-06 21 163 105 129.00 116.14 11.07%
2021-01-30 21 145 105 125.19 109.75 14.07%
2021-01-23 21 145 90 124.48 116.91 6.48%
2021-01-16 21 145 90 123.76 107.69 14.92%
2021-01-09 21 145 90 123.76 112.07 10.43%
2021-01-02 21 145 90 123.91 95.85 29.27%
2020-12-26 21 161 90 125.48 97.67 28.47%
2020-12-19 21 161 90 125.33 101.43 23.56%
2020-12-09 21 161 90 126.05 91.97 37.06%
2020-12-07 21 161 90 126.43 91.07 38.83%
2020-11-10 22 161 90 125.75 87.58 43.58%
2020-10-27 21 161 105 138.38 100.14 38.19%
2020-09-28 21 161 120 140.29 97.40 44.03%
2020-09-26 21 161 120 140.29 97.70 43.59%
2020-09-08 21 161 120 140.29 109.77 27.8%
2020-08-31 21 161 120 140.29 116.42 20.5%
2020-08-04 21 161 120 140.29 120.16 16.75%
2020-07-22 21 152 105 135.14 130.42 3.62%
2020-07-15 21 152 101 132.48 135.15 -1.98%
2020-07-05 22 149 101 128.00 125.37 2.1%
2020-07-04 23 149 101 127.48 125.37 1.68%
2020-06-25 23 149 101 127.48 128.47 -0.77%
2020-06-17 23 147 101 126.39 NA NA%
2020-06-08 23 147 101 124.39 NA NA%

NBIX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.46 9 9 7 0 0 25

The Trend in the Broker Recommendations


NBIX's average broker recommendation rating worsened by 0.4 over the prior 16 months.

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • Neurocrine Biosciences Inc's number of analysts covering the stock is higher than 93.67% of all US stocks.
  • NBIX has a greater average analyst price target than 94.53% of Pharmaceutical Products stocks.
  • Neurocrine Biosciences Inc's upside potential (average analyst target price relative to current price) is higher than 17.41% of Pharmaceutical Products stocks.
  • NBIX has a lower variance in analysts' estimates than 21.49% of all US stocks.

In the Pharmaceutical Products industry, ABT, BMRN and BMY are the three stocks most similar to Neurocrine Biosciences Inc regarding the price target and analyst recommendation information presented here.

Is NBIX a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7218 seconds.